InvestorsHub Logo
Followers 0
Posts 7
Boards Moderated 0
Alias Born 07/28/2018

Re: None

Wednesday, 08/01/2018 11:34:35 PM

Wednesday, August 01, 2018 11:34:35 PM

Post# of 1643

Citius Pharmaceuticals Inc. (CTXR) having phase III product. Still trading below $3?


Quote

http://www.rttnews.com/2921898/xent-trims-revenue-outlook-ctxr-on-watch-busy-year-ahead-for-nlnk.aspx?refresh=1

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.